Appointments come as CREATE advances CRT-402, its lead in vivo CD19 CAR-T program, to clinical development for B cell-driven autoimmune disease CAMBRIDGE, Mass., May 14, 2026 /PRNewswire/ -- CREATE ...
Most U.S. voters want to make it easier to study psychedelics, and almost half think psychedelics should be legalized for therapeutic use, a new survey finds. The results suggest a broad surge in ...
Walk into any academic conference, and you will find a flock of bright minds, pacing beside large printed panels, rehearsing with their breath in tremor – the feared “two-minuter”. The taut eyes of ...
Recently there has been a lot of discussion about making government more efficient. Perhaps receiving the most attention has been the announcement by president-elect Donald Trump of a Department of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results